In order to further explore the role of Gal-3 in development and progression of the autoimmune cholangitis and to envisage the potential novel therapeutic strategies, we used Gal-3 deficient mice and Gal-3 inhibitor treatment in N. aromaticivorans induced PBC. The gene discussed is LGALS3; the disease is primary biliary cholangitis.